Cost-effectiveness of sevelamer in the treatment of hyperphosphatemia associated with chronic kidney disease in Mexico

被引：0
|
作者：
Idrovo, J. [1 ]
Rivas, R. [1 ]
Zapata, L. [1 ]
机构：
[1] Guia Mark, Mexico City, DF, Mexico
来源：
VALUE IN HEALTH | 2008年 / 11卷 / 03期
关键词：
D O I：
10.1016/S1098-3015(10)70949-9
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A301 / A301
页数：1
相关论文
共 50 条
  • [41] Cost-effectiveness of lipid lowering with statins and ezetimibe in chronic kidney disease
    Schlackow, Iryna
    Kent, Seamus
    Herrington, William
    Emberson, Jonathan
    Haynes, Richard
    Reith, Christina
    Collins, Rory
    Landray, Martin J.
    Gray, Alastair
    Baigent, Colin
    Mihaylova, Borislava
    Baxter, A.
    Young, A.
    Hill, M.
    Knott, C.
    Cass, A.
    Feldt-Rasmussen, B.
    Fellstrom, B.
    Grobbee, D. E.
    Gronhagen-Riska, C.
    Haas, M.
    Holdaas, H.
    Hooi, L. S.
    Jiang, L.
    Kasiske, B.
    Krairittichai, U.
    Levin, A.
    Massy, Z. A.
    Tesar, V.
    Walker, R.
    Wanner, C.
    Wheeler, D. C.
    Wiecek, A.
    Dasgupta, T.
    Herrington, W.
    Lewis, D.
    Mafham, M.
    Majoni, W.
    Reith, C.
    Emberson, J.
    Parish, S.
    Simpson, D.
    Strony, J.
    Musliner, T.
    Agodoa, L.
    Armitage, J.
    Chen, Z.
    Craig, J.
    de Zeeuw, D.
    Gaziano, J. M.
    KIDNEY INTERNATIONAL, 2019, 96 (01) : 170 - 179
  • [42] THE COST-EFFECTIVENESS OF SCREENING FOR MICROALBUMINURIA: A SIMULATION MODEL FOR CHRONIC KIDNEY DISEASE
    Hoerger, Thomas
    Witterborn, John
    Segel, Joel
    Burrows, Nilka Rios
    Eggers, Paul
    Pavkov, Meda
    Jordan, Regina
    Schoolwerth, Anton C.
    Willams, Desmond
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2009, 53 (04) : A42 - A42
  • [43] Cost-Effectiveness of Dapagliflozin for Non-diabetic Chronic Kidney Disease
    Rebecca L. Tisdale
    Marika M. Cusick
    Kelly Zhang Aluri
    Thomas J. Handley
    Alice Kate Cummings Joyner
    Joshua A. Salomon
    Glenn M. Chertow
    Jeremy D. Goldhaber-Fiebert
    Douglas K. Owens
    Journal of General Internal Medicine, 2022, 37 : 3380 - 3387
  • [44] Projecting the potential cost-effectiveness of dapagliflozin for chronic kidney disease in Kuwait
    Swidan, Ahmed
    Elsisi, Gihan Hamdy
    Ibrahim, Mohamed M. M.
    Aljazzar, Mohammad
    Sallam, Hossameldin Tawfik
    JOURNAL OF MEDICAL ECONOMICS, 2023, 26 (01) : 271 - 282
  • [45] COST-EFFECTIVENESS OF EMPAGLIFLOZIN IN PATIENTS AFFECTED BY CHRONIC KIDNEY DISEASE IN ITALY
    Di Costanzo, A.
    Uster, A.
    Vassallo, C.
    Fiorentino, F.
    VALUE IN HEALTH, 2023, 26 (12) : S73 - S73
  • [46] Use of surrogacy for women with chronic kidney disease: a cost-effectiveness analysis
    Farwell, Jennifer
    Wyatt, Solange
    Rueda, Jose
    Emerson, Jenna
    Page, Jessica
    Fowler, Jessica
    Allen, Allison
    Caughey, Aaron
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2013, 208 (01) : S153 - S153
  • [47] Hyperphosphatemia of chronic kidney disease
    Hruska, Keith A.
    Mathew, Suresh
    Lund, Richard
    Qiu, Ping
    Pratt, Raymond
    KIDNEY INTERNATIONAL, 2008, 74 (02) : 148 - 157
  • [48] COST-EFFECTIVENESS OF PALIVIZUMAB IN PREMATURE INFANTS AND CHILDREN WITH CHRONIC LUNG DISEASE IN MEXICO
    Major, I
    Pichardo-Pina, C. A.
    Sanchez-Casillas, J. L.
    Schmidt, R.
    Vo, P.
    VALUE IN HEALTH, 2015, 18 (07) : A834 - A834
  • [49] SYSTEMATIC REVIEW AND META-ANALYSIS OF SEVELAMER VERSUS CALCIUM-BASED BINDERS FOR THE TREATMENT OF HYPERPHOSPHATEMIA IN CHRONIC KIDNEY DISEASE
    Patel, Leena
    Bernard, Lisa M.
    Elder, Grahame J.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2014, 29 : 148 - 148
  • [50] COST-EFFECTIVENESS OF INTERVENTIONS FOR CHRONIC RENAL FAILURE IN MEXICO
    Arredondo, A.
    De Icaza, E.
    VALUE IN HEALTH, 2011, 14 (07) : A570 - A570
12345